PYL-c pylarify F18 piflufolastat injecti

Ended Awarded

Contract number
HT001423F0017
Awardee
Awarding agency
Obligated
$246,665

Award facts

Contract value 100% obligated
$246,664.93 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20889, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

Sofie CO. was awarded a $246,664.93 firm fixed price call against the PYLARIFY F18 PIFLUFOLASTAT INJECTI blanket purchase agreement by the Defense Health Agency. As the prime contractor, Sofie CO. will deliver the requested injectable drug PYLARIFY F18 PIFLUFOLASTAT to the agency through its parent company Sofie Biosciences, Inc. Performance will take place in Bethesda, Maryland by November 13, 2023. No set-aside designation was applied to this contract award to supply pharmaceutical products in support of the Defense Health Agency's medical readiness mission.

Quick answers

Who was awarded contract HT001423F0017?

HT001423F0017 was awarded to Sofie CO. by Defense Health Agency (Department of Defense) on November 14, 2022.

How much is contract HT001423F0017 worth?

The government has obligated $246,665 on HT001423F0017.

Is contract HT001423F0017 an order under another contract?

Yes. HT001423F0017 is a BPA call under HT001421A0014, a blanket purchase agreement.

Was contract HT001423F0017 competed?

The extent of competition for HT001423F0017 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login